Minerva Neurosciences Inc (NERV)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

1601 TRAPELO ROAD WALTHAM, MA 02451

Minerva Neurosciences, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops new therapies to treat central nervous system (CNS) and neuropsychiatric diseases and disorders.

Data based on most recent fiscal year report
Market Cap334.487 Million Shares Outstanding39.03 Million Avg Volume520.181 Thousand
1-Yr BETA vs S&P TR1.314 Current Ratio24.94 Quick Ratio24.94
View SEC Filings from NERV instead.

View recent insider trading info

Funds Holding NERV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NERV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DOYLE WILLIAM F EXECUTIVE CHAIRMAN

  • Officer
  • Director
510,511 2020-03-06 3

LEVINE MARK S. GENERAL COUNSEL

  • Officer
74,487 2020-03-02 0

LUTHRINGER REMY CEO

  • Officer
  • Director
0 2019-12-31 2

AHLHOLM FREDERICK W SVP, CHIEF ACCOUNTING OFFICER

  • Officer
0 2019-12-31 2

RACE GEOFF EVP, CFO & CBO

  • Officer
0 2019-12-31 2

REILLY JOSEPH H. SVP & CHIEF OPERATING OFFICER

  • Officer
0 2019-12-31 2

DAVIDSON MICHAEL CHIEF MEDICAL OFFICER

  • Officer
0 2019-12-31 1

SAOUD JAY SVP AND HEAD OF R&D

  • Officer
0 2019-12-31 1

RUSSELL RICHARD E. PRESIDENT

  • Officer
0 2019-12-31 2

SMITH DEVIN WHITTEMORE SVP AND GENERAL COUNSEL

  • Officer
0 2019-12-31 1

HILLEMAN JERYL L

0 2019-12-03 2

VAN HEEK G JAN

  • Director
13,333 2019-06-26 2

KUPFER DAVID

  • Director
247,123 2019-06-26 2

HASLER HANS PETER

  • Director
10,000 2019-06-26 2

INDEX VENTURE ASSOCIATES III LTD

INDEX VENTURE ASSOCIATES IV LTD

INDEX VENTURE ASSOCIATES V LTD

YUCCA (JERSEY) SLP

  • 10% Owner
3,899,189 2019-06-24 2

LAGHRISSI-THODE FOUZIA

  • Director
0 2019-05-31 1

JOHNSON & JOHNSON

JOHNSON & JOHNSON INNOVATION - JJDC, INC.

  • 10% Owner
No longer subject to file 2018-07-19 0

CARE CAPITAL III LLC

CARE CAPITAL INVESTMENTS III L.P.

CARE CAPITAL OFFSHORE INVESTMENTS III LP

  • 10% Owner
No longer subject to file 2018-04-18 0

VIVALDI COELHO ROGERIO EVP, CHIEF GLOBAL THERAPEUTICS

  • Officer
No longer subject to file 2018-03-08 0

BEER MARC D

  • Director
0 2018-01-31 0

VANDERVELPEN NICO

  • Director
No longer subject to file 2017-07-24 0

OLLIER MICHELE

  • Director
  • 10% Owner
4,690,906 2016-12-12 0

DE RUBERTIS FRANCESCO

  • Director
  • 10% Owner
4,690,906 2016-12-12 0

PELLEGRINI LORENZO

  • Director
  • 10% Owner
3,883,212 2014-07-07 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments